Deep ResearchBuyer GuideNovember 16, 2026 · 43 min read · VEMERIX

How to Verify a 1470 nm EVLA Fiber–Console Pairing Before Award in 2026

Evaluate the exact fiber and console in a 1470 nm EVLA tender using their labeled compatibility, bench evidence and controls on post-award substitutions.

Illustration of optical fiber alignment and a power measurement bench.

Illustrative Procurement Scenario

Consider a hypothetical bid for an outpatient venous ablation service. A distributor quotes a 1470 nm console with 600 µm radial fibers. The bid includes the console clearance, a quality certificate in the distributor's name and brochures listing matching SMA-905 connections. Six months after award, the distributor sends a substitute without advance notice. In this invented sequence the console stops with an error, and the team finds conflicting diameter labels on the carton and pouch. Staff hold the stock and use the approved backup supply while the supplier identifies the affected lots.

One FDA record describes a console rejecting a kit because the RFID expiry disagreed with the carton label. A separate record describes a mismatch between inner and outer pouch labels. The public records opened for this article describe no failure following a distributor substitution. The scenario tests what the contract and the receiving team would do if that happened 3 4.

Scope: Applicable Regulatory Frameworks and Jurisdictional Boundaries

Evaluating an EVLA fiber-console pairing requires an understanding of the legal frameworks governing the tender jurisdiction. Medical device market authorizations, manufacturing quality standards, and post-market vigilance obligations are established by territorial legislation. The destination market’s rules apply. A foreign authorization can support an application where the destination market provides a reliance or recognition route.

Tender JurisdictionGoverning Authority & Statutory FrameworkConsumable Delivery Fiber RequirementsActive Diode Console RequirementsObligated Regulated EntityInter-Device Pairing & Co-Use Regulatory Standard
United StatesU.S. FDA; Federal Food, Drug, and Cosmetic Act (FD&C Act); 21 CFR Part 820 (QMSR) 5, 6510(k) premarket notification under Product Code GEX (21 CFR 878.4810, Class II) 5; GUDID UDI listing 7510(k) premarket notification under Product Code GEX (21 CFR 878.4810, Class II) 5; radiation safety certification 8, 9Finished device legal manufacturer named on 510(k) summary and FDA establishment listing 10Cleared indications for use and labeling define intended light sources; e.g., open-port fiber labeling (K252745) 1 vs recommended bare fiber (K252564) 2
European UnionEuropean Commission / National Competent Authorities; EU MDR 2017/745 11CE marking with classification assessed under MDR Annex VIII. Verify the relevant certificate and EUDAMED entries 11 12CE marking with the applicable active-device classification under MDR Annex VIII, including Rule 9. Verify the relevant certificate and EUDAMED entries 11 12Legal manufacturer identified on EU Declaration of Conformity and Single Registration Number (SRN) 11Mutual compatibility per manufacturer IFU; convenience procedure packs governed strictly by EU MDR Article 22 11
ChinaNational Medical Products Administration (NMPA); State Council Order No. 739 13Domestic Class II Medical Device Registration (predominantly provincial MPA) or Import Registration 14, 15Domestic National Class III Medical Device Registration (NMPA headquarters) or Import Registration 14Registrant named on the certificate. The registrant or its entrusted manufacturer holds the production licence 13VEMERIX suggests checking the approved product technical requirements and certificate structure-and-composition field for the registered configuration 13 15

Other markets set their own rules. Some rely on a reference authorization. This article covers the United States, the European Union and China.

For an EU tender verify a valid CE marking supported by the appropriate MDR certificate or a Directive certificate still valid under the MDR Article 120 transitional provisions as amended 11 16. China registration Lu Mech Reg. 20192010517 is for the VEMERIX disposable medical laser fiber and applies in China. VEMERIX states that this laser fiber is outside the scope of its CE-marked products. Exclude this fiber from EU-market bids on the present authorization record 15 17 13. This guide relies on no U.S. authorization for the VEMERIX fiber.

Start with the quoted model numbers. A bidder can show that a manufacturer has had them authorized together as a system or kit, or can provide separate records for the fiber and console. Compare the exact labels, legal manufacturer names, listed manufacturing sites and the instructions for use before treating a general family clearance as evidence for the quoted models.

Classification Scope and Regulatory Separation

In the United States, surgical diode laser consoles and sterile laser delivery fibers fall under FDA Product Code GEX (Powered Laser Surgical Instrument, 21 CFR 878.4810, Class II, General and Plastic Surgery panel) 5. Audit teams must verify product-code hygiene when reviewing vendor regulatory documentation. For example, introducer catheters and access sheaths packaged inside endovenous procedure kits often carry distinct premarket clearances under Product Code DYB (Catheter Introducer, 21 CFR 870.1340, Class II, Cardiovascular panel) 18. The two device types are listed under different regulations and review panels 5, 18.

Within Product Code GEX, device titles in premarket notifications can obscure the physical nature of the cleared device. Across 2,895 deduplicated FDA GEX 510(k) clearances recorded through October 30, 2026, an automated keyword classification of cleared device names identifies at least 935 explicit laser consoles or systems, 304 explicit standalone laser delivery fibers or accessories, and 150 paired fiber-plus-console systems or procedural kits 19. However, 1,506 clearances—representing 52.0% of all GEX records—could not be assigned by the device-type keyword rules 19. Among the 47 clearances that explicitly include endovenous, 1470 nm, saphenous, or varicose vein terms in their public titles, 20 cover paired systems and fibers, 10 cover consoles alone, 3 cover dedicated procedure kits, 1 explicitly titles a standalone fiber, and 13 remained unclassified by the device-type keyword rules 19. Because the keyword rules left over half of GEX titles unassigned, use FDA's 510(k) database to locate the records and inspect the full 510(k) Summary PDF and the cleared Indications for Use statement for every proposed device model 19.

Standalone Fiber vs. Diode Console Clearances in Public 510(k) Summaries

Publicly available FDA 510(k) summaries illustrate the technical and regulatory distinction between active diode consoles and passive optical fibers. On July 2, 2025, Micro-Energy Medical Technology Co., Ltd. obtained 510(k) clearance K251049 for the SurgiLight 1470 Diode Laser System (Model: Halo) 20. The clearance summary defines an active Class 4 surgical laser generator delivering 12 W continuous-wave, single-pulse, and repeat-pulse output at 1470 nm, equipped with a 650 nm (under 2.6 mW) red aiming beam, pulse durations from 5 ms to 9,000 ms, repetition rates from 0.06 Hz to 100 Hz, microprocessor control with Basic Documentation Level software validation, and compliance with IEC 60601-2-22:2019, IEC 60601-1-2:2014+A1:2020, and IEC 60825-1:2014 20. In Section 5, the applicant explicitly states that the console "transmits the laser output via optical fibers with SMA905 connectors" 20. Its predicate comparison demonstrates that surgical consoles vary across optical parameters: predicate console Wuhan Pioon S1 Pro (K240644) utilizes a 650 nm red aiming beam, whereas G.N.S. Neo Laser neoV1470 (K152722) employs a 532 nm (under 5 mW) green aiming beam 20. A passive delivery fiber must transmit both the invisible 1470 nm working beam and the visible aiming wavelength without excessive attenuation or beam distortion.

Five months later, on December 12, 2025, the same manufacturer received a separate, standalone 510(k) clearance, K252745, for its Halo Sterile Single-use Radial Fiber 1. Covering silica core diameters of 0.40 mm and 0.60 mm with listed outer diameters of 0.9 mm and 1.3 mm, the consumable is rated for 1 W to 30 W across a broad transmission spectrum of 500 nm to 2200 nm 1. In Section 8 of the summary, the applicant states that the device has no software 1. In its cleared Indications for Use, the manufacturer states that the fibers "are intended for use with any cleared surgical laser with an SMA 905 connector" 1.

Similarly, WON TECH Co., Ltd. obtained clearance K232106 on January 8, 2024, for its Air Gap Fiber family (272 µm, 365 µm, and 550 µm Low-OH silica cores, rated 1 W to 120 W, 980 nm to 2200 nm) with labeling declaring compatibility with "any surgical laser configured with an SMA-905 connector" 21. However, hospital legal teams must note that the clearance letters opened for this review each carry FDA's standard sentence: "CDRH does not evaluate information related to contract liability warranties" 20, 1, 21. While an open-port 510(k) summary establishes premarket substantial equivalence for regulatory commercialization, it provides no contractual protection if a capital console manufacturer attempts to void equipment warranty coverage following the connection of a third-party consumable fiber 1.

Worked Example: Cross-Auditing a Diode Console Recommendation Against a Radial Fiber Summary

To understand how premarket summary data guides procurement decisions, consider a hypothetical evaluation comparing a cleared diode laser console against a cleared standalone radial fiber. No such commercial bid is known to have been submitted, and this pairing is evaluated strictly to illustrate the audit methodology. On November 7, 2025, Baoding Te'anzhou Electronic Technology Co., Ltd. obtained clearance K252564 for the Medical Diode Laser Systems (VeinCure) (0.1 W to 15 W output, continuous and pulsed modes up to 50 Hz, Class I Type B electrical safety, IPX1 console housing, IPX8 footswitch, under 3 mW 650 nm aiming beam) 2. In Item 17 of its comparison table (Application / Light delivery system), the console manufacturer specifically recommends coupling the generator with a cleared disposable optical fiber from MED-Fibers, Inc. (K124003) and defines five specific technical parameters:

  • Delivery device style: bare fiber up to 3 m in length 2;
  • Fiber core diameter: 600 µm 2;
  • Numerical aperture: NA greater than or equal to 0.22 2;
  • Connector standard: SMA-905 connector 2;
  • Single-use status: strictly single-use disposable 2.

The VeinCure summary names MED-Fibers K124003 as its example delivery system. The procurement decision should use the console summary and the applicable fiber instructions 2 22.

Now evaluate a tender proposal where a distributor bids the VeinCure console (K252564) 2 paired with the Micro-Energy Halo Sterile Radial Fiber (K252745) 1. Cross-auditing the two public summaries reveals critical points of alignment and divergence:

  1. Wavelength and connector alignment. The console operates at 1470 nm with an SMA-905 port 2. The Halo fiber is rated for 500 nm to 2200 nm and terminates in an SMA-905 connector 1. On paper, the wavelength falls within the fiber’s stated range and both summaries name SMA-905.
  2. Core diameter and numerical aperture. Item 17 lists a 600 µm core and NA of at least 0.22 2. K252745 lists 0.40 mm and 0.60 mm core models and gives no numerical aperture 1. The 0.60 mm models match the stated core. Request the NA of the quoted fiber and the console manufacturer’s permitted core and NA range for that exact model.
  3. Power rating margin. The VeinCure console generates a maximum output of 15 W 2. The Halo summary gives a maximum output power of 1 W to 30 W and specifies no duty cycle 1. On paper, its maximum is twice the console’s maximum. Verify performance under the allowed launch conditions on the bench.
  4. Consumable geometry. Item 17 of the VeinCure summary identifies a bare fiber 2. The Halo summary describes a radial-type fiber with a conical distal end that radiates radially. It lists a 1.3 mm outer diameter for the 0.60 mm core models and leaves the measurement location unspecified 1. Ask for the manufacturer’s dimensioned drawing.
  5. Introducer catheter sizing. If the widest section is 1.3 mm (0.051 inch), use a sheath with a verified inner lumen larger than 1.3 mm, allowing for tolerance and valve passage. If the drawing specifies a larger tip dimension, size the sheath to that larger dimension. A nominal 4 Fr or 5 Fr designation cannot establish the usable inner lumen. Confirm the sheath model’s specified inner diameter and passage under the manufacturer’s instructions.
  6. Warranty and validation gap. Because the console manufacturer's public summary explicitly recommends a bare fiber under K124003 2, pairing it with a radial fiber under K252745 falls outside the console manufacturer's published baseline 1. The committee should require the bidder to furnish written documentation from the console manufacturer confirming the warranty coverage and the calibration procedure for the proposed radial-tip pairing.

Exposing Contract Manufacturing Chains in Establishment Registration and Device Listing

A 510(k) applicant name can represent a corporate brand owner rather than the physical manufacturing facility. Under FDA's Establishment Registration and Device Listing regulations (21 CFR Part 807), facilities that manufacture, package, label, or sterilize medical devices must register with FDA and list their activities 10.

Across 1,789 active listing rows under Product Code GEX, covering 483 unique FEIs and 485 registration numbers (August 24, 2026 snapshot), the extract lists 202 specification-development, 181 contract-manufacturing and 130 contract-sterilization activity mentions 10. A single listing can contain multiple activities. Request separate identifiers for the named parties in the quoted supply chain.

Reported Operational Activities Across GEX Establishment Registrations
Manufacture Medical DeviceActivity Mentions: 949949Complaint File Establishment(Historical Label)Activity Mentions: 320320Develop Specifications (Do NotManufacture At Facility)Activity Mentions: 202202Repack or Relabel Medical DeviceActivity Mentions: 186186Contract Manufacturer(Manufacture for Another Party)Activity Mentions: 181181Contract Sterilizer (Sterilizefor Another Party)Activity Mentions: 130130Export Device to the UnitedStates OnlyActivity Mentions: 124124Remanufacture Medical DeviceActivity Mentions: 1313Foreign Private LabelDistributorActivity Mentions: 77
View chart data
CategoryActivity Mentions
Manufacture Medical Device949
Complaint File Establishment (Historical Label)320
Develop Specifications (Do Not Manufacture At Facility)202
Repack or Relabel Medical Device186
Contract Manufacturer (Manufacture for Another Party)181
Contract Sterilizer (Sterilize for Another Party)130
Export Device to the United States Only124
Remanufacture Medical Device13
Foreign Private Label Distributor7

Specification development, contract manufacture and contract sterilization appear as separate activities. The chart counts mentions across 1,789 active listing rows covering 483 FEIs and 485 registration numbers.

  • Mentions represent reported activity instances across active device listings. 71 rows represent specification developers with specification development as their sole listed activity; 129 rows represent contract sterilizers with sterilization as their sole listed activity.

Source: FDA Establishment Registration & Listing Database - VEMERIX analysis, snapshot August 24, 2026

Public 510(k) filings confirm this operational division. In Special 510(k) K230819 (cleared April 21, 2023), specification owner Omni-Guide Holdings, Inc. explicitly states in the opening section of its summary that "LightGuide Optics International Ltd., is our Contract Manufacturer (CMO), a CMO of equivalent fibers (reference FDA Establishment Registration & Device Listing ID# 3012669557)" and notes that manufacturing and sterilization processes mirror fibers produced by LightGuide Optics 23. Twenty months later, on December 21, 2024, LightGuide Optics International Ltd. obtained direct 510(k) clearance K243147 for its own brand of surgical laser fibers (145 µm to 1000 µm, bare and side-fire tips, SMA-905 connector) 24.

For each model, request the legal manufacturer, the actual fabrication and sterilization facilities, their street addresses and evidence of their roles. For a U.S. offering, verify applicable registration and listing, including each applicable FEI and activity. For EU and China offerings, verify the entities and facilities against applicable conformity, registration and manufacturing records. A buyer that also requests U.S. evidence for a non-U.S. offer should state that additional buyer condition explicitly 10 11 13.

GUDID Device Identifier Verification: Consumable vs. Capital Profile Flags

FDA's Global Unique Device Identification Database (GUDID) provides an empirical mechanism to verify whether a proposed device identifier corresponds to a single-use sterile consumable or a capital equipment asset 7. Across 6,574 live GEX Device Identifiers (DIs) recorded in openFDA GUDID records as of November 2026, device attributes reflect distinct operational flags 7:

Distribution of Key Attribute Flags Across GEX Device Identifiers
For Single-Use (true)Percentage of GEX DIs (%): 36.136.1Device Packaged as Sterile(true)Percentage of GEX DIs (%): 39.239.2Kit / Convenience Procedure Pack(true)Percentage of GEX DIs (%): 3.33.3Requires Sterilization Prior toUse (true)Percentage of GEX DIs (%): 21.621.6
View chart data
CategoryPercentage of GEX DIs (%)
For Single-Use (true)36.1
Device Packaged as Sterile (true)39.2
Kit / Convenience Procedure Pack (true)3.3
Requires Sterilization Prior to Use (true)21.6

The single-use, sterility and kit flags tell buyers which labeling and packaging claims to verify. The chart summarizes flags for 6,574 GEX device identifiers.

  • Total live GEX DIs = 6,574. Attribute flags reflect manufacturer-reported master data elements in AccessGUDID. Reusable delivery fibers and accessories exist under GEX alongside single-use consumables.

Source: FDA AccessGUDID Database via openFDA - VEMERIX analysis, snapshot November 2026

  1. Single-Use vs. Reusable Status. Across all live GEX records, 2,372 DIs (36.1%) carry the For Single-Use flag, while 4,202 DIs (63.9%) are designated reusable 7. If a bidder quotes a single-use radial fiber whose GUDID record indicates that For Single-Use is false, the hospital may be receiving a reusable fiber that requires central sterile supply department (CSSD) reprocessing.
  2. Sterility and Sterilization Method. Packaged sterile devices account for 2,576 DIs (39.2%) under Device Packaged as Sterile, while 3,998 DIs (60.8%) are non-sterile, and 1,420 DIs (21.6%) specify sterilization prior to clinical use 7. A fiber has to be sterile when it enters the vein. The prior-to-use sterilization flag directs the buyer to the manufacturer’s reprocessing instructions and the local sterile processing workflow. VEMERIX recommends a supplier-sterilized single-use fiber for this application. For a device requiring hospital sterilization, request the validated instructions and confirm the hospital can follow them.
  3. Kit and Procedure Pack Configuration. Only 217 GEX DIs (3.3%) represent convenience kits or procedure packs (Kit = true), compared with 6,357 individual device records (96.7%) 7. Bidders quoting bundled convenience kits packaging the delivery fiber alongside vascular introducers and guidewires should furnish a primary DI that corresponds to a multi-component procedure pack.

Procurement officers must recognize that GUDID flags describe regulatory and packaging attributes rather than rigid device type definitions. Both reusable and single-use delivery fibers exist under Product Code GEX 7. Use the GUDID record for the applicable U.S. device package to verify the model, labeling flags and package hierarchy. Reconcile a separate shipping label against the delivery record 7.

China NMPA Classification Framework: Provincial Class II Fibers vs. National Class III Consoles

In the People's Republic of China, medical device registration establishes distinct catalog entries and management classes for passive optical delivery fibers and active surgical laser generators. Under the NMPA Medical Device Classification Catalogue (2017 Announcement No. 104), surgical lasers and delivery systems fall under Sub-catalogue 01 (Active Surgical Devices), Category 01-02 (Laser surgical equipment and accessories) 14:

  • Laser Surgical Equipment (Entry 01-02-01). Encompassing semiconductor diode lasers, CO2 lasers, Nd:YAG lasers, and solid-state lasers used for human tissue cutting, vaporization, and coagulation, all active surgical consoles are classified as Class III medical devices 14. Class III devices require premarket technical review by the National Center for Medical Device Evaluation (CMDE) and registration approval by NMPA 13.
  • Medical Laser Optical Fibers (Entry 01-02-02). Passive optical fibers and delivery accessories that couple to laser equipment to transmit therapeutic energy are classified as Class II medical devices 14. Domestic Class II registrations fall under the administrative jurisdiction of provincial-level medical products administrations in the registrant’s province 13.

For imported Class II and III devices, the designated Chinese corporate agent submits to the national regulator under Article 16 of Order 739. For a domestic quote, compare the province, registrant and production details with the national query before relying on a certificate 13 15.

Within this statutory framework, Weihai Medison Medical Equipment Co., Ltd. (established in Weihai, Shandong Province in 2003, operating an ISO 13485 quality system) holds provincial Class II medical device registration Lu Mech Reg. 20192010517 for its single-use VEMERIX Disposable Medical Laser Fiber 15, 17. The registration is for a Class II disposable medical laser fiber. Confirm the scope of application and quoted model against the current certificate and instructions 15 17.

Conversely, an active 1470 nm diode laser generator offered in a Chinese tender must hold its own independent Class III registration certificate matching the specific console model number 14. When evaluating bids in China or reviewing Chinese registration documentation, tender committees should confirm that each offered device holds an active registration certificate for the quoted model: domestic fibers typically hold provincial Class II certificates, imported devices hold NMPA import registrations, and active consoles hold Class III registrations 14, 15. Evaluators should also inspect the "Structure and Composition" (jiegou ji zucheng) field of the console certificate to verify whether any specific optical fiber is registered as part of the capital equipment system 15.

European Union MDR 2017/745 Governance: Economic Operators and Procedure Packs

In the European Union, the commercial bundling of optical fibers and laser consoles is governed by Regulation (EU) 2017/745 on Medical Devices (EU MDR) 11. EU MDR establishes clear boundaries for economic operators:

  1. Distributor and Importer Obligations (Article 16). Under Article 16(1), an importer or distributor assumes manufacturer obligations if it makes a device available under its own name, registered trade name or trademark, subject to the agreement exception below. Manufacturer obligations also apply when it changes the intended purpose of a device already placed on the market or put into service, or modifies such a device in a way that may affect compliance with applicable requirements 11. Article 16(1)(a) provides an explicit exception where a distributor or importer enters into an agreement with a legal manufacturer under which the manufacturer is identified as such on the label and remains responsible for meeting MDR requirements 11. For a device already placed on the market, Article 16(2) covers translation of supplied information and changes to existing outer packaging needed to market that device in the Member State, under the applicable conditions. Packaging changes must leave the original device condition unaffected. For sterile devices, opening, damaging or otherwise impairing packaging necessary to maintain sterility presumptively affects the original condition. The importer or distributor must meet the Article 16(3) quality-system requirements and, under Article 16(4), notify the manufacturer and competent authority at least 28 days before making the relabeled or repackaged device available and provide the authority with the applicable notified-body certificate 11.
  2. Procedure Packs and Systems (Article 22). Combining separately CE-marked components—such as a sterile laser fiber, vascular introducer sheath, puncture needle, and guidewire—into an endovenous convenience kit is governed by Article 22 11. Under Article 22(2), the person combining the devices must draw up a mutual compatibility declaration verifying that the components were combined in accordance with the manufacturers' instructions and that operations were carried out under appropriate internal control methods 11. Under Article 22(3), a person sterilizing a pack or system for placement on the market follows the applicable Annex IX or Annex XI Part A procedure, with notified-body involvement limited to aspects of achieving and maintaining sterility until opening or damage. The person draws up a statement that sterilization followed the manufacturer’s instructions 11. Under Article 22(4), a pack or system is treated as a device in its own right and requires the relevant conformity assessment if it includes a device without CE marking, the selected combination is incompatible with the original intended purpose, or sterilization departed from the manufacturer’s instructions. The person combining the products assumes manufacturer obligations 11.

Tender committees must also exercise caution when evaluating European Database on Medical Devices (EUDAMED) records. Pursuant to Commission Decision (EU) 2025/2371 and Article 123 as amended, mandatory use of the declared EUDAMED modules began on May 28, 2026 25 26. However, transitional registration timelines established under Regulation (EU) 2024/1860 permit extended uploading windows for certain pre-existing legacy devices 26. Consequently, check the supplier’s conformity documents when a device profile is absent from a mid-2026 public EUDAMED snapshot 12 26.

For an EU bid, verify each device’s applicable conformity evidence, including the declaration of conformity and certificate where required. Determine whether the bidder translates, relabels, repackages or combines devices. Add the applicable Article 16 documentation or Article 22 statement when those activities require it 11.

2. Optical Interface Physics, Output Calibration, and Standards Verification

Confirming legal-manufacturer attribution verifies regulatory provenance; evaluating optical interface physics confirms whether therapeutic light is safely launched from the diode console into the fiber and delivered to the targeted vein wall without proximal thermal damage or distal power loss.

Mechanical Envelope (IEC 61754-22 Type F-SMA) vs. Optical and Thermal Realities

IEC 61754-22 identifies standard interface dimensions for the type F-SMA connector family in its published scope. The full text is paywalled. For this purchase, use the manufacturers' specifications and instructions to check core diameter, numerical aperture, end-face geometry, maximum continuous-wave power and permitted mating conditions. Those checks are VEMERIX engineering recommendations inferred from the connector standard's mechanical scope. Ask the bidder to show how the two named models fit together 27 1 2.

Proximal Connector Architecture: Crimp, Air-Gap, and Epoxied SMA-905 Assemblies

The two named console summaries give maximum outputs of 12 W for K251049 and 15 W for K252564. The Halo radial fiber in K252745 is rated to 30 W. Request the rating and permitted duty cycle for the exact quoted fiber 20 2 1.

VEMERIX engineering hypothesis: stray or reflected optical energy at the ferrule can contribute to local heating if coupling is poor. Ask for thermal qualification evidence at the console's permitted test settings and examine the returned connector if a failure occurs. Omni-Guide's summary describes its crimp as suitable where heat matters and its epoxy as a lower-cost option for other applications. WON TECH names its product Air Gap Fiber. These are manufacturer descriptions of specific cleared products 23 21.

Distal Working-Beam Accuracy: Federal Measurement Rule and Bench Metrology

Under the direct US federal standard, 21 CFR 1040.11(a)(1) requires manufacturers of Class III or IV medical laser products to include a means of measuring the radiation intended to irradiate the human body. The means may have a measurement error of up to 20% when calibrated per the supplied procedures in paragraph (a)(2). The rule contains a limited exception for low-level positioning radiation. IEC 60601-2-22 separately addresses laser equipment safety and essential performance 28 29.

VEMERIX proposes a ±20% bench acceptance tolerance for a cross-vendor pair. A pair passes when the measured distal power at every agreed setting is within ±20% of the console setting and its measurement uncertainty interval stays within the same limits. Record the detector’s uncertainty beside each reading. When that interval crosses a limit, mark the result inconclusive and repeat the test with a suitable setup before accepting the pairing. Optical attenuation determines the power that reaches the vein. As VEMERIX engineering judgment, clinical engineering should use an integrating sphere or a detector calibrated for radial emission. Have the lab document the detector's wavelength range, uncertainty and how it captures the circumferential beam. A forward-facing sensor alone may miss energy emitted laterally.

Why Delivered Power Matters: Energy per Centimeter

In endovenous laser ablation, clinicians adjust console power and catheter pullback speed to achieve an intended Linear Endovenous Energy Density (LEED, expressed in J/cm). The rationale for verifying optical transmission accuracy is to ensure that delivered energy matches clinical dosing expectations. For example, at a console power of 8 W and a pullback rate of 1.5 mm/s (equivalent to 6.7 s/cm), the intended nominal LEED is 53.3 J/cm. If an uncalibrated fiber-console pairing incurs an unmeasured 25% to 30% distal coupling loss, delivered energy drops to 40.0 J/cm to 37.3 J/cm.

One meta-analysis of randomized trials found no significant difference in anatomical success between the studied energy ranges or wavelength categories 30. SVS/AVF/AVLS Recommendation 4.1.1 favors endovenous ablation over high ligation and stripping for intervention candidates with symptomatic varicose veins and axial reflux in the great saphenous vein (Grade 1, Level B) 31. That recommendation addresses treatment selection. The guideline does not set a delivered-power tolerance. The proposed delivered-power tolerance comes from the bench protocol above.

In a separate systematic review of 1470 nm EVLA, Bontinis and colleagues report an across-study meta-regression over 69–101.7 J/cm. Higher energy density was associated with greater great saphenous vein occlusion at 2, 3 and 5 years. The power check is a calibration and protocol-fidelity control. The cited studies give no estimate of patient harm for a specific shortfall in delivered power 32.

Laser Radiation Safety and Federal Certification Routes in the United States

In the United States, medical laser consoles must comply with Electronic Product Radiation Control (EPRC) regulations under 21 CFR 1040.10 and 1040.11 8, 9. Historically, FDA's Laser Notice No. 50 permitted manufacturers to demonstrate conformance with equivalent International Electrotechnical Commission (IEC) standards 9. However, FDA officially withdrew Laser Notice No. 50 on December 31, 2024 9.

For U.S. tenders, check these three ordinary certification approaches 8, 9:

  1. Legacy Laser Notice No. 50. Consoles certified under Laser Notice No. 50 prior to January 1, 2025, may enter U.S. commerce following submission of a qualifying product report 9;
  2. Direct Federal Standard. Consoles certified on or after January 1, 2025, demonstrating direct compliance with 21 CFR 1040.10 and 1040.11 8, 9;
  3. Laser Notice No. 56 Alternative. Consoles certified on or after January 1, 2025, utilizing the alternative approach outlined in Laser Notice No. 56 (February 2023), under which FDA exercises enforcement discretion for platforms conforming to IEC 60825-1 Edition 3 and IEC 60601-2-22 Edition 3.1 8, 9.

If the manufacturer relies on a variance, review FDA’s granted variance and verify that the device and proposed configuration meet its terms. A pending application alone is insufficient. Tender committees evaluating consoles in the U.S. should request the manufacturer's laser product report accession number and inspect the certification label on the console chassis to confirm the specific federal certification route utilized 8, 9.

Consumable Safety Dossier: Sterilization, Packaging Integrity, and Biocompatibility Evidence

K252745 Section 8 shows the evidence one ethylene-oxide-sterilized radial fiber presented to FDA. Its sterilization test-report list names 13 standards covering sterilization, ethylene oxide residuals, endotoxin, package integrity and sampling. A separate list reports 11 biocompatibility tests under ISO 10993 1:

  • Sterilization Validation. Ethylene oxide sterilization development and routine control per ISO 11135:2014, bioburden enumeration per ISO 11737-1:2018, sterility testing per ISO 11737-2:2019, biological indicator testing per ISO 11138-1/-2, ethylene oxide residuals per ISO 10993-7:2008, and bacterial endotoxin testing per ANSI/AAMI ST72:2019 1. K232106 also identifies the 2018 amendment to ISO 11135 21.
  • Packaging Barrier Integrity. Seal strength testing via ASTM F88/F88M-21, dye penetration testing via ASTM F1929-15, bubble leak testing via ASTM F2096-11, and visual inspection via ASTM F1886/F1886M-16 1. Accelerated aging protocols validating sterile barrier shelf life are documented under ASTM F1980-21 in K232106 21, while primary packaging compliance under ISO 11607-1 is documented in K230819 23.
  • Biological Evaluation. For externally communicating blood-path devices with limited exposure (24 hours or less) 21, K252745 documents cytotoxicity (ISO 10993-5), skin sensitization (ISO 10993-10), intracutaneous irritation (ISO 10993-23), systemic toxicity and pyrogenicity (ISO 10993-11), hemocompatibility, thrombosis, hemolysis, and complement activation (ISO 10993-4), and genotoxicity (ISO 10993-3) 1.

Ask the bidder for equivalent evidence applicable to the sterilization method and contact category of the quoted fiber. Check the tested configuration and exposure category against its instructions 1 21 23.

FDA Recognized Consensus Standards Transitions: Premarket Declarations vs. Marketed Status

Procurement officers reviewing FDA Recognized Consensus Standards must understand the precise scope of published transition dates 33, 34. For sterile barrier packaging and laser electrical safety, FDA's consensus standards database records two notable transition dates:

  1. Sterile Packaging (ISO 11607-1 & ISO 11607-2). Recognition #14-530 and #14-531 (ISO 11607-1:2019 and ISO 11607-2:2019) list a transition expiration date of December 20, 2026, superseded by Recognition #14-594 and #14-595 (ISO 11607-1:2019+AMD1:2023 and ISO 11607-2:2019+AMD1:2023) 33 35.
  2. Laser Safety and Essential Performance (IEC 60601-2-22). Recognition #12-268 (IEC 60601-2-22 Edition 3.1:2012) lists a transition expiration date of July 4, 2027, superseded by Recognition #12-356 (IEC 60601-2-22 Edition 4.0:2019) 34. Furthermore, IEC webstore records indicate that IEC published an amendment in 2026 (IEC 60601-2-22:2019+AMD1:2026) 29.

Crucially, FDA's consensus standards database explicitly defines the operational effect of these dates:

"FDA will accept declarations of conformity, in support of premarket submissions, to [Rec#] until [date]." 33, 34

These transition dates apply to declarations of conformity submitted in new premarket submissions to FDA 33, 34. Existing clearances remain in effect through these standard transitions 33, 34. In a tender context, inquiring about standards editions serves an informational purpose: it enables the committee to confirm whether the manufacturer maintains contemporary quality documentation and whether planned mid-contract product modifications will transition smoothly through future regulatory submissions 33, 34.

Evaluating Commercial Procurement Strategies: Single-Manufacturer Systems vs. Open-Port Cross-Vendor Pairings

VEMERIX makes fibers sold for use with other manufacturers' consoles. The comparisons below are VEMERIX assessments. Verify each point for the bid and proposed contract.

Procurement optionPoints to verifyEvidence to ask for
Single-manufacturer system or kitOne authorization may cover the combination. Check proprietary consumable availability, service response and actual warranty terms.System authorization, current instructions for use, compatibility list, warranty and alternate supply plan.
Cross-vendor pairing on an open SMA-905 portMultiple suppliers may be available. Check how each party accepts a complaint, how the optical interface is qualified and who pays for a failed component investigation.Both model records, written interface specification, bench evidence and agreed warranty allocation.

In recall Z-2444-2019, AngioDynamics' RFID chip expiry of April 2014 disagreed with the carton expiry of March 31, 2022. The console gave an error and prevented use. FDA recorded the cause as under investigation by the firm. Ask how the bidder tests chip-to-carton data and whether the hospital can verify a replacement lot using its installed software build 3.

3. What FDA Post-Market Surveillance Records Show (and What They Do Not Prove)

Analyzing post-market adverse event reports and device recalls provides practical insight into real-world hardware failure modes, helping tender committees design effective pre-award bench tests and contract terms.

Methodological Scope and Boundaries of Adverse Event Reporting (MAUDE)

FDA's Manufacturer and User Facility Device Experience (MAUDE) database contains mandatory reports from manufacturers, importers and user facilities and voluntary reports from health professionals, patients and consumers. FDA's November 4, 2026 openFDA snapshot had 44,761 records for product code GEX, including 8,881 classified as injury (19.84%) 36 37.

MAUDE lacks procedure volume and device exposure denominators. Reports can be incomplete or unverified. Higher counts can reflect more exposure or heightened reporting. Use the records to identify potential failure modes to investigate 36.

Reported Product Problems in the 771 Venous Laser Keyword Matches

The search in Method returned 771 GEX reports. Fracture was the most frequent code (229 reports), and 80 reports carried the code “Adverse Event Without Identified Device or Use Problem,” about one in ten. The chart displays the nine most frequent codes as returned. 268 reports carried one or more other codes, and a report can appear in multiple bars 38 39.

Most Frequent Problem Codes in 771 GEX Keyword Matches
FractureReports with code: 229229CrackReports with code: 8282Adverse Event Without IdentifiedDevice or Use ProblemReports with code: 8080Detachment of Device or DeviceComponentReports with code: 6363Device Damaged Prior to UseReports with code: 5858Detachment Of Device ComponentReports with code: 5353BreakReports with code: 4747Insufficient Device ProblemInformationReports with code: 4646Thermal Decomposition of DeviceReports with code: 3535
View chart data
CategoryReports with code
Fracture229
Crack82
Adverse Event Without Identified Device or Use Problem80
Detachment of Device or Device Component63
Device Damaged Prior to Use58
Detachment Of Device Component53
Break47
Insufficient Device Problem Information46
Thermal Decomposition of Device35

Fracture was the most frequent code. The chart shows the nine most frequent exact codes. 268 reports carried other codes, and one report could carry several codes.

  • MAUDE is a passive surveillance database. Without procedure exposure denominators, these are counts of reports carrying each exact code. Of the 771 reports, 268 carried at least one code outside the bars and four carried no product problem code.

Source: FDA MAUDE via openFDA. Queried November 13, 2026; data updated November 4, 2026. Exact query and counts in Method and Sources.

The codes alone do not identify the failed component. Product records in the recall examples below cover fibers, kits and accessories. Use the observed codes to design a receiving test, then check each offered model and its instructions separately 36 3 40 41.

FDA Recall Records With Implications for Receiving and Bench Checks

The GEX recall query returned 201 product-specific recall action lines across 101 event numbers through August 6, 2026. One recall event can include multiple models and lots. The four linked records inform different tender controls 4 3 40 41 42.

FDA recall records and the checks they inform
FDA recordProduct and firmReported issueFDA-determined causeTender check
Z-0585-2008SlimLine 200 Micron Holmium Fiber; LumenisOuter pouch 200 µm; inner pouch label 365 µmLabeling mix-upsCompare both pouch labels
Z-2444-2019VenaCure EVLT NeverTouch Procedure Kit; AngioDynamicsRFID and carton expiry differUnder investigation by firmCompare digital and printed expiration dates
Z-2228-2023Flexiva Pulse 242 Single-Use Laser Fiber; Boston ScientificIncorrect component with potential low output and connector heatingNonconforming Material/ComponentAsk for component and connector qualification evidence
Z-2159-2015Sureflex reusable fibers; American Medical SystemsCleaning and sterilization validation gapReprocessing ControlsVerify applicable reprocessing instructions for reusable items

Selected FDA GEX recall records illustrate four tender and receiving checks. The records involve different laser products and uses.

Source: FDA Medical Device Recall records. Record links appear in the surrounding text.

The Flexiva Pulse 242 record concerns a urology fiber. Verify the exact EVLA pair independently 40. Ask which accessories in the quote are reusable and request the reprocessing instructions for each, a check informed by the Sureflex recall 41.

4. Pre-Award Tender Evaluation Worksheet, Physical Bench Protocol, and Contract Terms

To translate regulatory registers, standards transitions, and recall data into practical procurement governance, evaluation committees can incorporate two structured instruments into their tender documentation: an objective Ten-Domain Verification Worksheet and a three-sample physical bench acceptance protocol.

Evaluation committees must recognize the legal nature of the tools presented in this section. The verification worksheet, technical scoring weights, bench testing parameters, and contract rider clauses are VEMERIX's editorial suggestions and recommended buyer controls derived from regulatory and engineering records. They do not constitute statutory regulations or universal public procurement mandates.

Public laws and regulatory frameworks—such as FDA 510(k) clearances 19, NMPA device registrations 14, and EU MDR conformity declarations 11—bind finished device manufacturers and legal economic operators. The specific pre-award change controls, dock verification remedies, and advance notification obligations emphasized in this guide are contractual mechanisms established between the purchasing authority and the supplier in the Master Supply Agreement.

For U.S. procedure-volume context, VEMERIX’s Medicare utilization analysis tracks services billed under the thermal laser ablation codes CPT 36478 and 36479 from 2013 to 2024, combining facility and office settings 43 44. The analysis describes billed procedures and provider payments. Keep those figures separate from the equipment and consumables quote.

Ten-Domain Pairing Verification and Change-Control Matrix

The following matrix maps underlying rules and suggested buyer controls across ten critical evaluation domains, providing a defensible scoring framework for pre-award technical evaluation:

Ten-Domain 1470 nm EVLA Pairing Verification and Change-Control Matrix
DomainUnderlying Rule (Jurisdiction & Obligated Entity)Buyer Control Suggested by VEMERIXEvidence to RequestPre-Award Verification Method
1. Market Authorization & Legal AttributionStatutory: FD&C Act (US; manufacturer); EU MDR (EU; manufacturer); State Council Order 739 (China; registrant)Eligibility gate: one authorization covering both models or separate exact-model authorizationsExact-model authorization and labeling. For EU bids obtain each device’s applicable declaration of conformity and certificate. Add Article 16 documentation or an Article 22 statement when the activity requires it.Confirm each model, its legal manufacturer and current status in the tender jurisdiction
2. Console Internal Registration / PTR ScopeStatutory: PRC Medical Device Registration (China; registrant)Tender technical requirement: Confirm whether console registration specifies coupled fibersApproved Product Technical Requirements (PTR) and Structure & Composition field of console certificateInspect console certificate composition field to determine whether third-party fibers are registered with console
3. Fabrication and sterilization facilitiesU.S. registration and listing under 21 CFR Part 807 where applicable. Use corresponding destination-market requirements.Identify each legal entity, actual facility and its role.Facility names and addresses, applicable registration or manufacturing evidence, and U.S. FEIs and listing where applicable.Confirm the named activities and facilities. Score equivalent destination-market evidence; exclude genuinely inapplicable subchecks.
4. Device-package identity and hierarchyU.S. UDI where applicable, or destination-market identifiers and labeling rules.Verify the exact model and the packaging level of each DI.Applicable base and package DIs, quantities and packaging specification; lot and expiry recorded separately.Resolve each Package DI to the approved base-package DI and quantity. Check single-use and sterility flags where applicable. Reconcile shipping-container labels separately.
5. Proximal Optical Connector ArchitectureNone; voluntary consensus standard (IEC 61754-22 Type F-SMA) used for mechanical envelopeTender engineering specification: Mandatory disclosure of ferrule termination method and power ratingEngineering cross-section drawing; connector termination method (crimp, air-gap, or epoxied); CW power ratingInspect manufacturer technical documentation; confirm rated continuous-wave power at 1470 nm exceeds console output
6. Console Radiation Certification & Output Accuracy21 CFR 1040.10 and 1040.11(a)(1) (US; laser product manufacturer). IEC 60601-2-22 addresses equipment safety and performance.Confirm federal certification route. VEMERIX proposes ±20% in the documented cross-vendor bench setup.Console label and accession number. Record detector, power, test settings and uncertainty.Use a suitable detector and follow both sets of instructions. The measurement uncertainty interval must stay within ±20% of each setpoint to pass the buyer test.
7. Consumable Sterility & Packaging ValidationSterilization and packaging validation support market authorization (manufacturer). ISO 11135 and ISO 10993-7 for EO, ISO 11137 for radiation, and ISO 11607 for packaging are voluntary means. Providing them to the buyer is a proposed tender condition.Tender quality requirement: validation for the sterilization method actually used and sterile-barrier evidenceMethod and batch, method-specific validation summary and packaging qualificationMatch the release records and finished product to the method and packaging in the quoted dossier
8. Biological Safety & HemocompatibilityBiological evaluation supports market authorization (manufacturer). ISO 10993-1 and ISO 10993-4 are voluntary means. Providing them to the buyer is a proposed tender condition.Tender safety requirement: Full ISO 10993 blood-contact panel for externally communicating devicesISO 10993-4 hemocompatibility test reports; ISO 10993-5 cytotoxicity; ISO 10993-10 sensitization; ISO 10993-11 toxicityInspect biocompatibility summary; confirm testing performed on finished, terminally sterilized fiber
9. Mechanical Catheter Tracking & ClearanceNone; voluntary consensus standards and clinical engineering best practiceTender acceptance testing: Physical tracking through stocked vascular introducers and hemostasis valvesExact IFU-permitted sheath model, verified lumen and valve clearance for the maximum fiber diameter and tolerances. State any local French-size requirement separately as a buyer condition.Confirm drawing dimensions and verify passage through the specified lumen and valve under the IFU bend-radius limit. Verify lock engagement where the configuration includes a lock.
10. Contractual Change-Control & Supply Chain WhitelistContractual: Private bilateral Master Supply Agreement between Hospital and SupplierContractual mandate: Frozen product schedule, 60-day change notice, dock quarantine, and 48-hr remedySigned contract rider incorporating Exhibit A whitelist and change-notification obligationsLegal review of tender terms; establish incoming receiving-dock quarantine and inspection workflow

Use the first row as the authorization gate. The remaining rows map the checks for eligible bids to evidence, from labels and sterilization to the bench protocol and change terms.

Source: VEMERIX Procurement & Regulatory Advisory Matrix - November 2026

Illustrative Technical Scoring Rubric and Statutory Weighting Constraints

This illustrative 100-point model assigns 85 points to technical verification and 15 to price. Apply any local weighting requirement.

Market authorization for every quoted model is a pass/fail gate before scoring. Apply these illustrative groups to bids that meet the gate:

  • Group A, disclosure quality (20 points, matrix rows 1–4). Score exact-model and entity matches, named fabrication and sterilization facilities, the applicable registration evidence and the packaging-level identifier crosswalk. Give equivalent destination-market records the same credit. Mark a truly inapplicable subcheck N/A and normalize the remaining applicable subchecks to the 20-point group. Mandatory applicable authorization and safety gates still apply.
  • Group B, interface, power and passage (25 points, rows 5, 6 and 9). Score whether documentation covers the connector and duty cycle, the console's federal route where relevant, controlled output checks and smooth passage through the nominated sheath.
  • Group C, sterile barrier and biological safety (20 points, rows 7 and 8). Ask for validation for the method used, including ISO 11135 and ISO 10993-7 for ethylene oxide or ISO 11137 for radiation. Include finished-device packaging and biological evaluation evidence 1 21 33 45.
  • Group D, contract terms (20 points, row 10). Score the specificity and enforceability of the agreed schedule, notice, quarantine and replacement terms.
  • Group E, price (15 points). Score the quoted cost of the fiber and console plus service, spare accessories and maintenance.

Some jurisdictions set a minimum price weight. For example, in the People's Republic of China, Ministry of Finance Order No. 87 (Measures for the Administration of Bidding and Tendering for Government Procurement of Goods and Services), Article 55, mandates that under comprehensive evaluation methods, the price score for goods tenders may not be lower than 30% of total evaluation weight (and not lower than 10% for service tenders) 46. Consequently, public hospitals operating in jurisdictions with statutory pricing floors must adjust weighting allocations (e.g., 70% technical / 30% price) to remain legally compliant while maintaining rigorous technical baselines.

Pre-Award Physical Acceptance Protocol: Three-Sample Bench Sequence

Prior to contract award, clinical engineering departments should conduct a physical acceptance bench test on shortlisted pairings:

  • Prerequisites and laser safety. Obtain written authorization from the Laser Safety Officer. Use a controlled area and protection selected by the LSO under ANSI Z136.3 or the applicable national standard. Follow the instructions for both models, including limits on exposure, settings and measurement medium. Where either set of instructions precludes the setup or the detector is unavailable, commission a hospital-witnessed manufacturer test or an accredited third-party test and record which was used. Keep bench samples out of clinical stock and use 47.
  • Step A, labels and packaging. Pull three sealed units from separate cartons. Match core diameter, tip style, lot, expiry and device identifiers at each labeled level. Inspect the seal for visible damage. Quarantine discrepancies and log both label images 4.
  • Step B, sheath and valve. Use a stocked sheath that the instructions allow, and stay within the fiber's minimum bend radius. Verify smooth passage, full engagement of any lock, and extension of the emission zone beyond the sheath. Record which fiber and sheath models were used.
  • Step C, controlled optical check. Connect the fiber to the console the hospital will use and record the serial number and software build. Verify recognition and the aiming pattern under the allowed setup. Measure distal power at the agreed settings and duration with a detector appropriate for radial emission. Record setpoint, observed output, measurement uncertainty, and whether the pairing meets the proposed ±20% acceptance rule above. Stop and investigate any interlock or damage. Hold any outside or inconclusive result for review. Keep the unit isolated pending review 28.

Receiving-Dock Verification, Lot Quarantine, and User Facility Vigilance

Pre-award vetting provides lasting protection only when reinforced by incoming materials management and clinical engineering vigilance:

  1. Lot documentation. Ask for a lot-specific release record with the sterilization method and batch. Match the evidence to the method: ISO 11135 and ISO 10993-7 for ethylene oxide, or ISO 11137 for radiation. Hold unmatched deliveries 1 21 45.
  2. Decode device-package identifiers. For each applicable packaging level, decode the device identifier (DI) separately from production identifiers such as lot and expiry. For U.S. products subject to UDI, resolve a Package DI through GUDID and the supplier’s packaging specification to the approved base-package Primary DI and quantity. Verify the exact model and packaging hierarchy, including applicable single-use and sterility flags. Use corresponding destination-market identifiers and packaging evidence elsewhere. A shipping-container barcode supports logistics reconciliation separately from the device-package UDI. Quarantine a model, hierarchy, production-identifier or seal mismatch 7.
  3. Preservation for failure analysis. Retain the failed fiber and, where available, an unopened sample from the same lot. Handle and store the device under facility biohazard policy and the manufacturer's return instructions. Log the lot and console configuration and contact the manufacturer's complaint unit.
  4. User facility adverse event reporting. In the United States, hospitals and ambulatory surgical centers are legally bound by 21 CFR 803.30 48. Under 21 CFR 803.30, user facilities must report device-related deaths to FDA and the manufacturer within 10 work days, and report device-related serious injuries directly to the manufacturer (or to FDA if the manufacturer is unknown) within 10 work days, utilizing FDA Form 3500A 48.

Structuring Enforceable Mid-Contract Change-Control Terms in the Master Supply Agreement

Use the supply agreement to set the supplier’s notice and delivery duties. The FDA Quality Management System Regulation (QMSR, 21 CFR Part 820, effective February 2, 2026) incorporates ISO 13485:2016 by reference 6. Clauses 7.3.9 and 7.4 of ISO 13485:2016, which QMSR incorporates, address design changes and purchasing controls 6 49. Similarly, FDA's non-binding guidance document Deciding When to Submit a 510(k) for a Change to an Existing Device (October 2017) assists manufacturers in evaluating whether a device modification requires a new premarket clearance under 21 CFR 807.81(a)(3) 50.

These instruments are addressed to finished device manufacturers. The hospital establishes its remedies against the supplier in the supply agreement. Furthermore, if a distributor switches from the awarded manufacturer's fiber to a different manufacturer's product, that action represents a commercial substitution rather than a design modification within the original manufacturer's Clause 7.3.9 system 6. Counsel can adapt the illustrative clauses below to the Master Supply Agreement.

  • Clause 1: Frozen Product Schedule and Facility Whitelist (Illustrative Draft). “Supplier shall deliver only the models, destination-market device identifiers at the applicable packaging levels, named legal manufacturers, fabrication facilities, contract manufacturers and sterilization facilities listed in the jurisdiction-specific Exhibit A. For U.S. models subject to applicable registration, listing or UDI requirements, record the corresponding FEIs, Primary DIs, Package DIs and package quantities. For other markets, record equivalent required identifiers and facility evidence. Hospital may reject any substitution or delivery from an unlisted site without prior written approval.”
  • Clause 2: Mandatory 60-Day Advance Notification of Modifications (Illustrative Draft). "Supplier shall provide written notice to Hospital at least sixty (60) calendar days prior to the shipment of any device lot affected by a design modification, constituent material change, component supplier substitution, or manufacturing facility relocation. The notice shall include written documentation confirming that the modification has been validated under the legal manufacturer's quality management system and that measured distal output remains within the acceptance tolerance set in the Hospital’s bench acceptance protocol (Exhibit B)."
  • Clause 3: Receiving Quarantine, 48-Hour Replacement, and Indemnification (Illustrative Draft). "Any delivered lot failing dock verification, exhibiting barcode discrepancies, or delivered without required advance change notice shall be quarantined at Supplier's sole expense. Supplier shall deliver fully conforming replacement product within forty-eight (48) hours of notification. Supplier shall defend, indemnify, and hold harmless Hospital, its clinical staff, and its biomedical personnel against any claims, regulatory recall expenses, procedural cancellations, or equipment repair liabilities resulting from unapproved device substitutions."

Method and Limitations

Data Sources, Extraction Parameters, and Access Dates

This analysis synthesizes public regulatory registers, consensus standards databases, and post-market surveillance records verified across specific snapshots:

  • Premarket Notifications (510(k)). Queried via openFDA Device 510(k) API and FDA's public 510(k) database for Product Code GEX (snapshot through October 30, 2026, cumulative n = 2,895 clearances) 19. Public summaries inspected include K251049 20, K252745 1, K252564 2, K232106 21, K230819 23, K243147 24, and K124003 22.
  • Establishment Registration and Listing. Queried via openFDA Device Registration and Listing API for Product Code GEX (snapshot of August 24, 2026, yielding 1,789 active listing rows across 483 unique FEIs and 485 registration numbers) 10.
  • Global Unique Device Identification Database (GUDID). Queried via openFDA Device UDI API for Product Code GEX (snapshot through November 2026, yielding 6,574 live Device Identifiers) 7.
  • Adverse Event Surveillance (MAUDE). Ran openFDA on November 13, 2026 (database last updated November 4, 2026). The GEX event-type query yielded 44,761 reports 37. The following exact subset query yielded 771. Counted exact product_problems values without merging labels 38 39.

``text device.device_report_product_code:GEX AND (device.brand_name:(EVLA OR EVLT OR 1470 OR saphenous OR varicose) OR device.generic_name:(EVLA OR EVLT OR 1470 OR saphenous OR varicose) OR mdr_text.text:(EVLA OR EVLT OR 1470 OR saphenous OR varicose)) ``

  • Medical Device Recalls. Queried via openFDA Device Recall API for Product Code GEX (snapshot through August 6, 2026, yielding 201 recall action lines across 101 distinct recall event numbers) 42.
  • China device classification and procurement records. Reviewed the 01-02-01 and 01-02-02 catalogue entries in NMPA Announcement No. 104 of 2017 and searched for 20192010517 on November 13, 2026. The Inner Mongolia Autonomous Region Healthcare Security Administration’s published negotiation table identifies that number, the Weihai Medison manufacturer and the disposable medical laser fiber. Verify current status against the original certificate and official registry at purchase 14 15 51.
  • European Union MDR / EUDAMED. Evaluated against Regulation (EU) 2017/745 Articles 16 and 22 11, Commission Decision (EU) 2025/2371 25, and Regulations (EU) 2024/1860 and 2023/607 26 16.

Analytical Categorizations and Grouping Rules

  • 510(k) Title Classification. Titles in GEX were categorized via automated keyword parsing into explicit consoles (keywords: laser system, diode laser, console, generator), explicit fibers/accessories (keywords: fiber, delivery system, optical fiber, probe), paired systems (containing both console and delivery terms, or kit), and unassigned titles matching none of the keywords 19.
  • Recall records. The chart identifies selected records using the manufacturer, reported reason and FDA-determined cause. The 201 action lines were counted by the recall query. No analyst assignment of every line to an object category or risk domain is used in the chart.

Methodological Limitations

  1. Absence of Exposure Denominators in MAUDE. MAUDE reports represent passive incident submissions without corresponding clinical procedure totals 36. Problem-code counts describe reporting volume rather than true failure incidence 36.
  2. Broad Scope of Product Code GEX. FDA Product Code GEX encompasses surgical lasers across several specialties 5. Aggregate GEX metrics reflect diverse surgical specialties alongside vascular ablation systems 5.
  3. Search coverage. The keyword query matches the specified fields. It can omit relevant records using other terminology and include records for different parts or procedures 38.
  4. Public Data Latency. Regulatory snapshots reflect reporting and processing lags, and registrations outside the U.S., EU, and China fall outside this dataset 15, 12.

Frequently Asked Questions

What evidence should a tender require for a cross-manufacturer fiber and console?

VEMERIX proposes the following procurement acceptance policy:

  1. Verify a current destination-market authorization covering both exact models, either together or through applicable individual records 5 14 11.
  2. Check the applicable instructions and labels for wavelength, power, connector and the proposed intended use. Verify the exact configuration with both manufacturers 1 21.
  3. Where instructions or labels restrict the combination, obtain written manufacturer documentation identifying the applicable labeling. Resolve the restriction through documented regulatory and technical review and hold the pairing outside ordinary acceptance while any conflict remains 2.
  4. Have clinical engineering perform the controlled acceptance check in Step C. Document the applicable warranty and support terms before clinical release.

How should an evaluation committee handle a console that enforces proprietary RFID or EEPROM fiber recognition?

Ask the bidder to demonstrate which tags are accepted on the installed software version. Match the digital and printed expiry, and check how the equipment logs an expired or unreadable tag. For a non-OEM offer, obtain the manufacturer compatibility evidence and written support terms before releasing the pairing for use 3.

Procurement Next Steps and Technical Dossier Requests

Four Practical Procurement Gates

  1. Verify a destination-market authorization covering both quoted models. Accept one system or kit authorization that names both or verify each model separately.
  2. Check the legal manufacturer, physical fabrication and sterilization sites, and identifiers against the registry and package labels.
  3. Under Laser Safety Officer supervision, verify sheath passage and distal power. Apply the proposed ±20% power criterion to the documented test setup.
  4. Freeze approved products and facilities in the contract, provide for advance substitution notice, and define incoming quarantine and replacement rights.

Technical Dossier Requests for Qualified Buyers

For procurement teams evaluating medical laser delivery consumables, Weihai Medison Medical Equipment Co., Ltd. manufactures the single-use VEMERIX Disposable Medical Laser Fiber, authorized under China NMPA Provincial Class II Medical Device Registration Lu Mech Reg. 20192010517 15, 17. Single-use, sterile, and individually packed with multiple tip geometries operating at 1470 nm, the VEMERIX fiber is manufactured under an ISO 13485 quality management system 15, 17.

Qualified hospital procurement committees, biomedical engineering departments, and authorized distributors assessing the China-market use described in Scope may request available technical documentation—including NMPA registration certificates, ISO 13485 quality certificates, and technical product specifications—under a standard mutual non-disclosure agreement (NDA) by contacting Weihai Medison Medical Equipment Co., Ltd. via VEMERIX Regulatory and Technical Support 17.

Sources

  1. U.S. Food and Drug Administration (FDA). 510(k) Summary K252745: Micro-Energy Medical Technology Co., Ltd. Halo Sterile Single-use Radial Fiber. FDA Summary K252745 PDF
  2. U.S. Food and Drug Administration (FDA). 510(k) Summary K252564: Baoding Te'anzhou Electronic Technology Co., Ltd. Medical Diode Laser Systems (VeinCure). FDA Summary K252564 PDF
  3. U.S. Food and Drug Administration (FDA). Medical Device Recall Enforcement Report: AngioDynamics VenaCure EVLT NeverTouch Procedure Kits (Recall Z-2444-2019, Record ID 174798, Event ID 83334). FDA Recall Record 174798
  4. U.S. Food and Drug Administration. Recall Z-0585-2008, SlimLine 200 Micron Holmium Fiber. Source record
  5. U.S. Food and Drug Administration (FDA). Product Classification Database: Product Code GEX (Powered Laser Surgical Instrument, 21 CFR 878.4810). FDA Classification Registry
  6. U.S. Food and Drug Administration (FDA). Quality Management System Regulation (QMSR) Final Rule (21 CFR Part 820, effective February 2, 2026; incorporating ISO 13485:2016). FDA QMSR Final Rule
  7. U.S. Food and Drug Administration (FDA). Global Unique Device Identification Database (AccessGUDID). National Library of Medicine AccessGUDID
  8. U.S. Food and Drug Administration (FDA). Laser Products — Conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 (Laser Notice No. 56). FDA Laser Notice No. 56 Guidance
  9. U.S. Food and Drug Administration (FDA). Getting a Radiation-Emitting Product to Market Frequently Asked Questions (Laser Notice 50 Transition, Q29–Q32). FDA Electronic Product Radiation Control FAQ
  10. U.S. Food and Drug Administration (FDA). Establishment Registration & Device Listing Database. FDA Registration & Listing Database
  11. European Parliament and Council. Regulation (EU) 2017/745 on Medical Devices (EU MDR), Articles 16, 22, 27, 120 and 123 and Annex VIII. EUR-Lex EU MDR 2017/745
  12. European Commission. EUDAMED — European Database on Medical Devices. EC EUDAMED Portal
  13. State Council of the People’s Republic of China. Regulations for the Supervision and Administration of Medical Devices, Order 739, as amended. Source record
  14. National Medical Products Administration (NMPA, China). Notice on Publishing the Medical Device Classification Catalogue (2017 Announcement No. 104). NMPA Classification Announcement
  15. National Medical Products Administration. Medical Device Data Query. NMPA data query. Select domestic medical devices and search registration number 20192010517, including the Shandong registration prefix.
  16. European Parliament and Council. Regulation (EU) 2023/607 amending the medical-device transition rules.
  17. VEMERIX (Weihai Medison Medical Equipment Co., Ltd.). Which Part Is the Device? How Public Registers Separate Endovenous Laser Fibers, Generators and Kits (2026). VEMERIX Register Comparison Report
  18. U.S. Food and Drug Administration (FDA). Product Classification Database: Product Code DYB (Catheter Introducer, 21 CFR 870.1340). FDA Classification Registry
  19. U.S. Food and Drug Administration (FDA). 510(k) Premarket Notification Database. FDA 510(k) Premarket Notification Database
  20. U.S. Food and Drug Administration (FDA). 510(k) Summary K251049: Micro-Energy Medical Technology Co., Ltd. SurgiLight 1470 Diode Laser System. FDA Summary K251049 PDF
  21. U.S. Food and Drug Administration (FDA). 510(k) Summary K232106: WON TECH Co., Ltd. Air Gap Fiber. FDA Summary K232106 PDF
  22. U.S. Food and Drug Administration (FDA). 510(k) Summary K124003: MED-Fibers, Inc. Surgical Laser Fibers and related probes. FDA Summary K124003 PDF
  23. U.S. Food and Drug Administration (FDA). 510(k) Summary K230819: Omni-Guide Holdings, Inc. OmniGuide RFID Surgical Laser Fibers (OmniGuide PRIMA in the indications form). FDA Summary K230819 PDF
  24. U.S. Food and Drug Administration (FDA). 510(k) Summary K243147: LightGuide Optics International Ltd. LGO-Surgical Laser Fibers. FDA Summary K243147 PDF
  25. European Commission. Commission Decision (EU) 2025/2371 on EUDAMED functionality. Source record
  26. European Parliament and Council. Regulation (EU) 2024/1860 of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the gradual roll-out of EUDAMED. EUR-Lex EU Reg 2024/1860
  27. International Electrotechnical Commission (IEC). IEC 61754-22:2005 Edition 1.0: Fibre optic connector interfaces — Part 22: Type F-SMA connector family. IEC Webstore 61754-22
  28. U.S. Food and Drug Administration. 21 CFR 1040.11: Specific purpose laser products. Source record
  29. International Electrotechnical Commission (IEC). IEC 60601-2-22:2019 Edition 4.0: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment. IEC Webstore 60601-2-22
  30. Malskat WSJ, Engels LK, Hollestein LM, Nijsten T, van den Bos RR. Commonly Used Endovenous Laser Ablation (EVLA) Parameters Do Not Influence Efficacy: Results of a Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery. 2019;58(2):230–242 (PMID 31230868). DOI 10.1016/j.ejvs.2018.10.036
  31. Gloviczki P, Lawrence PF, Wasan SM, et al. 2023 SVS/AVF/AVLS Clinical Practice Guidelines for Varicose Veins of the Lower Extremities, Part II. Recommendation 4.1.1.
  32. Bontinis V, Bontinis A, Giannopoulos A, Manaki V, Kontes I, Pitoulias AG, Chorti A, Ktenidis K. Mid-term and Long-term Outcomes of Endovenous Laser Ablation Utilizing a 1470 nm Laser a Systematic Review and Meta-Analysis. Journal of Endovascular Therapy. 2026;33(3):1126–1137. First published online 2024. Published study record
  33. FDA. ISO 11607-1 Recognition No. 14-594 and transition from No. 14-530.
  34. U.S. Food and Drug Administration (FDA). Recognized Consensus Standards Database: Recognition #12-356 (IEC 60601-2-22 Medical Electrical Laser Equipment Edition 4.0:2019). FDA Standards Database Rec# 12-356 Record 45390
  35. FDA. ISO 11607-2 Recognition No. 14-595 and transition from No. 14-531.
  36. U.S. Food and Drug Administration (FDA). Manufacturer and User Facility Device Experience (MAUDE) Database. FDA MAUDE Database Search
  37. openFDA. GEX device events by event type.
  38. openFDA. Venous laser keyword search and report count.
  39. openFDA. Venous laser keyword matches by exact problem code.
  40. U.S. Food and Drug Administration (FDA). Medical Device Recall Enforcement Report: Boston Scientific Flexiva Laser Fibers (Recall Z-2228-2023 through Z-2234-2023, Record ID 201721, Event ID 92570). FDA Recall Record 201721
  41. U.S. Food and Drug Administration. Class 2 recall Z-2159-2015, Sureflex reusable laser fibers, Event 71534. Source record
  42. U.S. Food and Drug Administration (FDA). Medical Device Recalls Database. FDA Medical Device Recalls Search
  43. Centers for Medicare & Medicaid Services (CMS). Medicare Physician & Other Practitioners by Provider and Service. CMS Provider Data Catalog
  44. VEMERIX (Weihai Medison Medical Equipment Co., Ltd.). From Stripping to Light: The Global Shift to Endovenous Ablation for Varicose Veins. VEMERIX Market Shift Report
  45. ISO. ISO 11137-1:2025, second edition. Sterilization of health care products. Radiation. Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices.
  46. Ministry of Finance of the People's Republic of China. Measures for the Administration of Bidding and Tendering for Government Procurement of Goods and Services (Ministry of Finance Order No. 87). Ministry of Finance Order No. 87
  47. Laser Institute of America. ANSI Z136.3-2024: Safe Use of Lasers in Health Care. ANSI catalog
  48. U.S. Food and Drug Administration. 21 CFR 803.30: Reports by user facilities. eCFR. See also · FDA device user facility reporting requirements
  49. ISO. ISO 13485:2016, third edition. Medical devices. Quality management systems. Requirements for regulatory purposes.
  50. U.S. Food and Drug Administration (FDA). Deciding When to Submit a 510(k) for a Change to an Existing Device: Guidance for Industry and Food and Drug Administration Staff (October 25, 2017). FDA 510(k) Modification Guidance
  51. Inner Mongolia Autonomous Region Healthcare Security Administration. Medical consumables procurement negotiation table, registration 20192010517.

Talk to VEMERIX

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.